Amyotrophic lateral sclerosis (ALS) is not a curable disease, but it is treatable. By definition,
much of the care provided to ALS patients is palliative, even though active life-sustaining …

The variable clinical course of Amyotrophic Lateral Sclerosis (ALS) confronts the clinician,
the patient and caregivers with many ethical challenges from the moment of breaking the …

This article examines some of the ethical concerns relevant for the management of
amyotrophic lateral sclerosis (ALS). We emphasize the importance for providing a …

The special nature of amyotrophic lateral sclerosis (ALS) and tracheostomy with invasive
ventilation (TIV) leads to challenges that can be difficult in two senses: not only to handle …

It is one of the primary goals of medical care to secure good quality of life (QoL) while
prolonging survival. This is a major challenge in severe medical conditions with a prognosis …

Abstract Objective: This study aims (1) to assess physicians' attitudes toward different
palliative end-of-life (EOL) practices in amyotrophic lateral sclerosis (ALS) care, including …

In an era where life-sustaining technology offers physicians unprecedented powers to
prolong survival in terminal illness, the question of how end of life decisions are made has …

Mechanical ventilation, both invasive and non-invasive, may be an effective means of
improving the quality of life and prolonging the survival of patients suffering from …

Decisions to prolong or shorten life in fatal diseases like amyotrophic lateral sclerosis are
strongly influenced by healthy individuals, such as caregivers and physicians. Furthermore …

Multidimensional socio-medical care with an early integration of palliative principles is
strongly recommended in amyotrophic lateral sclerosis (ALS), but provided inconsistently …